BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15930746)

  • 1. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.
    Gao JQ; Sugita T; Kanagawa N; Iida K; Okada N; Mizuguchi H; Nakayama T; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Biol Pharm Bull; 2005 Jun; 28(6):1066-70. PubMed ID: 15930746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy.
    Okada N; Gao JQ; Sasaki A; Niwa M; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Fujita T; Yamamoto A; Tsutsumi Y; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2004 Apr; 317(1):68-76. PubMed ID: 15047149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.
    Okada N; Sasaki A; Niwa M; Okada Y; Hatanaka Y; Tani Y; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A
    Cancer Gene Ther; 2006 Apr; 13(4):393-405. PubMed ID: 16224496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors.
    Gao JQ; Alexandre LS; Tsuda Y; Katayama K; Eto Y; Sekiguchi F; Mizuguchi H; Hayakawa T; Nakayama T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Pharmazie; 2004 Mar; 59(3):238-9. PubMed ID: 15074605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour activity of cationic-liposome-conjugated adenovirus containing the CCL19 [chemokine (C-C motif) ligand 19] gene.
    Cao M; Deng HX; Zhao J; Fan LY; Jiang Y; Wen YJ; Li J; Lei S; Mao YQ; Ding ZY; Wei YQ
    Biotechnol Appl Biochem; 2007 Oct; 48(Pt 2):109-16. PubMed ID: 17868025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.
    Gao JQ; Kanagawa N; Xu DH; Han M; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1657-64. PubMed ID: 18327579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
    Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
    Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
    Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Takahashi K; Hayakawa T; Mayumi T; Mizuno N
    Biochim Biophys Acta; 2004 Feb; 1670(3):172-80. PubMed ID: 14980444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
    Kanagawa N; Niwa M; Hatanaka Y; Tani Y; Nakagawa S; Fujita T; Yamamoto A; Okada N
    Int J Cancer; 2007 Nov; 121(9):2013-2022. PubMed ID: 17621629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors.
    Okada N; Masunaga Y; Okada Y; Iiyama S; Mori N; Tsuda T; Matsubara A; Mizuguchi H; Hayakawa T; Fujita T; Yamamoto A
    Cancer Gene Ther; 2003 May; 10(5):421-31. PubMed ID: 12719712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
    Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
    J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia.
    Okamoto M; Asamura A; Tanaka K; Soeda T; Watanabe K; Mizuguchi H; Ikeda T
    Vet Res Commun; 2016 Dec; 40(3-4):131-139. PubMed ID: 27744530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
    Mizuguchi H; Hayakawa T
    Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer.
    Hamanishi J; Mandai M; Matsumura N; Baba T; Yamaguchi K; Fujii S; Konishi I
    Stem Cells; 2010 Jan; 28(1):164-73. PubMed ID: 19911426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy.
    Gao JQ; Tsuda Y; Han M; Xu DH; Kanagawa N; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Cancer Immunol Immunother; 2009 Feb; 58(2):291-9. PubMed ID: 18629495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.